Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study.

Juergen Wolf; Tobias R. Overbeck; Ji-Youn Han; Maximilian Hochmair; Filippo de Marinis; Kadoaki Ohashi; Egbert F. Smit; Danielle Power; Edward B. Garon; Harry J. M. Groen; Daniel Shao-Weng Tan; Maeve Waldron-Lynch; Sylvie Le Mouhaer; Ngozi Nwana; Monica Giovannini; Rebecca Suk Heist

Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study.

Juergen Wolf, Tobias R. Overbeck, Ji-Youn Han, Maximilian Hochmair, Filippo de Marinis, Kadoaki Ohashi, Egbert F. Smit, Danielle Power, Edward B. Garon, Harry J. M. Groen, Daniel Shao-Weng Tan, Maeve Waldron-Lynch, Sylvie Le Mouhaer, Ngozi Nwana, Monica Giovannini, Rebecca Suk Heist

Onderzoeksoutput › Academic

Originele taal-2	English
Aantal pagina's	2
Tijdschrift	Journal of Clinical Oncology
Volume	38
Nummer van het tijdschrift	15
Status	Published - 20-mei-2020

Handle.net

Permanente koppeling

Citeer dit

Wolf, J., Overbeck, T. R., Han, J-Y., Hochmair, M., de Marinis, F., Ohashi, K., Smit, E. F., Power, D., Garon, E. B., Groen, H. J. M., Tan, D. S-W., Waldron-Lynch, M., Le Mouhaer, S., Nwana, N., Giovannini, M., & Heist, R. S. (2020). Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study. Journal of Clinical Oncology, 38(15).

@article{1f56a11c03fd487daa5d4d6d11e3aa68,

title = "Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study.",

author = "Juergen Wolf and Overbeck, {Tobias R.} and Ji-Youn Han and Maximilian Hochmair and {de Marinis}, Filippo and Kadoaki Ohashi and Smit, {Egbert F.} and Danielle Power and Garon, {Edward B.} and Groen, {Harry J. M.} and Tan, {Daniel Shao-Weng} and Maeve Waldron-Lynch and {Le Mouhaer}, Sylvie and Ngozi Nwana and Monica Giovannini and Heist, {Rebecca Suk}",

year = "2020",

month = may,

day = "20",

language = "English",

volume = "38",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "AMER SOC CLINICAL ONCOLOGY",

number = "15",

}

Wolf, J, Overbeck, TR, Han, J-Y, Hochmair, M, de Marinis, F, Ohashi, K, Smit, EF, Power, D, Garon, EB, Groen, HJM, Tan, DS-W, Waldron-Lynch, M, Le Mouhaer, S, Nwana, N, Giovannini, M & Heist, RS 2020, 'Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study.', Journal of Clinical Oncology, vol. 38, nr. 15.

TY - JOUR

T1 - Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC)

T2 - results from the phase 2 GEOMETRY mono-1 study.

AU - Wolf, Juergen

AU - Overbeck, Tobias R.

AU - Han, Ji-Youn

AU - Hochmair, Maximilian

AU - de Marinis, Filippo

AU - Ohashi, Kadoaki

AU - Smit, Egbert F.

AU - Power, Danielle

AU - Garon, Edward B.

AU - Groen, Harry J. M.

AU - Tan, Daniel Shao-Weng

AU - Waldron-Lynch, Maeve

AU - Le Mouhaer, Sylvie

AU - Nwana, Ngozi

AU - Giovannini, Monica

AU - Heist, Rebecca Suk

PY - 2020/5/20

Y1 - 2020/5/20

M3 - Meeting Abstract

VL - 38

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 15

ER -